Skip to main content

Advertisement

Log in

Risk Stratification of Medulloblastoma: A Paradigm for Future Childhood Brain Tumor Management Strategies

  • Clinical Trial Report
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Packer RJ, Gajjar A, Vezina G, et al.: Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 22006;24(25):4202.

  2. Kortmann RD, Kuhl J, Timmermann B, et al.: Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT’91. Int J Radiat Oncol Biol Phys 2000;46(2):269.

    Article  PubMed  CAS  Google Scholar 

  3. Packer RJ, Gurney JG, Punyko JA, et al.: Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 2003; 21(17):3255.

    Article  PubMed  Google Scholar 

  4. Packer RJ, Cogen P, Vezina G, et al.: Medulloblastoma: clinical and biologic aspects. Neuro Oncol 1999; 1(3):232.

    PubMed  CAS  Google Scholar 

  5. Rutkowski S, Bode U, Deinlein F, et al.: Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352(10): 978, 2005.

    Article  PubMed  CAS  Google Scholar 

  6. Gajjar A, Hernan R, Kocak M, et al.: Clinical, histopathologic, and molecular markers of prognosis: Toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 22:984–993, 2004.

    Article  PubMed  CAS  Google Scholar 

  7. Pfister S, Remke M, Benner A, et al.: Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27:1627–1638, 2009.

    Article  PubMed  Google Scholar 

  8. Kool M, Koster J, Bunt J, et al.: Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 2008;3(8):e3088.

    Article  PubMed  Google Scholar 

  9. Pomeroy SL, Tamayo P, Gaasenbeek M, et al.: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442, 2002.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roger J. Packer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Packer, R.J. Risk Stratification of Medulloblastoma: A Paradigm for Future Childhood Brain Tumor Management Strategies. Curr Neurol Neurosci Rep 11, 124–126 (2011). https://doi.org/10.1007/s11910-010-0168-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-010-0168-5

Keywords

Navigation